Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $45.1600 (-3.26%) ($45.1300 - $46.6600) on Mon. Feb. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 54 | Latest Price | $45.1600(-3.26%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BAX advances 2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(36%) IWD(35%) SPLV(35%) SDY(34%) ARKG(32%) | Factors Impacting BAX price | BAX will decline at least -1.135% in a week (0% probabilities). VIXM(-22%) VXX(-11%) MCHI(-11%) GLD(-11%) FXI(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | -2.3 () | Intraday Trend | -3% | | | |
|
Resistance Level | $45.35 | 5 Day Moving Average | $46.16(-2.17%) | 10 Day Moving Average | $45.93(-1.68%) | 20 Day Moving Average | $45.35(-0.42%) | To recent high | -20.1% | To recent low | 3.5% | Market Cap | $23.04b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |